Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
SER compared with ENVB: revenue, margins and what each company keeps, and the suppliers and customers both name
SER
Serina Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
ENVB
Enveric Biosciences, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
SER
Serina Therapeutics, Inc.
vs
ENVB
Enveric Biosciences, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
SER: latest quarter is a loss; flow not drawable. ENVB: latest quarter not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only SER
1
PFE
Pfizer
customer
Shared
0
No disclosed counterparties: ENVB.
Only ENVB
0
None
Role chip = supplier or customer
Source: SEC EDGAR
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
SER, solid
ENVB, dashed
SER
Serina Therapeutics, Inc.
Change
1.93
▲
+2.12%
· post 1.98
Mkt cap
$31.8M
Revenue
$130,000
Q2 FY25
ENVB
Enveric Biosciences, Inc.
Change
1.43
▼
−2.05%
· post 1.43
Closed
Oct 30 '26
Mkt cap
$6.4M
Revenue
—
vs
Compare
Closed
Oct 30 '26
SER
Serina Therapeutics, Inc.
vs
ENVB
Enveric Biosciences, Inc.
1.93
▲
+2.12%
post 1.98
Price
1.43
▼
−2.05%
post 1.43
$31.8M
Mkt cap
$6.4M
Q2 FY25
$130,000
Revenue
—
Change
Change
SER
1.93
▲
+2.12%
vs
ENVB
1.43
▼
−2.05%
Closed
Oct 30 '26